Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Terumo's Hepaflush Prefilled Syringes Selling Well
August 19, 2002
- BUSINESS NEWS IN BRIEF
August 19, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 19, 2002
- AMO Japan Sees Split from Allergan as a Major Advantage: President Akedo
August 19, 2002
- OTC NEWS IN BRIEF
August 19, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 5, 2002
- Olympus: New Version of EndoALPHA
August 5, 2002
- Eisai to Promote Pfizer's Cerebyx in US
August 5, 2002
- Olympus ProMarketing: Periodontal Disease Prevention Tool PerioMicro
August 5, 2002
- Fujisawa Ties Up with MerLion of Singapore for Enzyme Research
August 5, 2002
- Hitachi Medical to Gear Up New Business, Overseas Marketing
August 5, 2002
- Wholesalers Must Finish Price Negotiations by Mid-year Settlement of Accounts: Mr Matsutani
August 5, 2002
- Bayer Medical: Multistix Urinalysis Strips for Renal Disease Detection
August 5, 2002
- Price Agreement Rates Are Slightly Better Than in 2000: Azwell
August 5, 2002
- Kyowa Medex to Exclusively Market NID Diagnostic Products
August 5, 2002
- BUSINESS NEWS IN BRIEF
August 5, 2002
- WORLD NEWS IN BRIEF
August 5, 2002
- Website News
August 5, 2002
- BUSINESS BULLETIN
August 5, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
August 5, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…